Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Mai M. Anwar"'
Autor:
Mai M. Anwar, Ibrahim M. Ibrahim Laila
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Vortioxetine (VORTX) is a potent and selective type of selective serotonin reuptake inhibitor (SSRI) that is mainly prescribed for treating major depression along with mood disorders as the first drug of choice. Limited previous f
Externí odkaz:
https://doaj.org/article/69bc90952d174e49858596a39241b46f
Autor:
Mohamed E. El awady, Sahar S. Mohamed, Mostafa M. Abo Elsoud, Manal G. Mahmoud, Mai M. Anwar, Mahgoub M. Ahmed, Ashraf Eltaher, Sameh Magdeldin, Ashraf Attallah, Ali E. Elhagry, Sayeda A. Abdelhamid
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-23 (2024)
Abstract Inflammation is a part of the body’s intricate biological reaction to noxious stimuli and defensive reactions. So, the aim of this investigation was to study the anti-inflammatory activity of exopolysaccharide (EPSSM) using carrageenan-ind
Externí odkaz:
https://doaj.org/article/206ff131f42740ff90b799f2e63fb684
Autor:
Mai M. Anwar
Publikováno v:
Ibrain, Vol 9, Iss 1, Pp 63-71 (2023)
Abstract Despite decades of repeated and intense research, the etiology of sudden Alzheimer's disease (AD) symptoms is still unclear. AD progressive pathology mainly involves neuron damage, depositions of amyloid‐beta (Aβ), and hyperphosphorylated
Externí odkaz:
https://doaj.org/article/c48c81885e744376880d2f696a7d1899
Autor:
Mai M. Anwar, Ibrahim M. Ibrahim Laila
Publikováno v:
BMC Complementary Medicine and Therapies, Vol 22, Iss 1, Pp 1-11 (2022)
Abstract Background Among the most commonly consumed non-steroidal anti-inflammatory drugs (NSAID) is Diclofenac (Dic), especially in low-income countries due to its high efficiency and affordable price. However, the continuous administration of Dicl
Externí odkaz:
https://doaj.org/article/faa368a64c5b40768713b2e5f9c45860
Autor:
Mai M. Anwar, Esra Özkan, Narges Shomalizadeh, Selin Sapancı, Ceyda Özler, Judy Kesibi, Yasemin Gürsoy-Özdemir
Publikováno v:
Frontiers in Neuroscience, Vol 16 (2023)
Alzheimer’s disease (AD) is a predominantly heterogeneous disease with a highly complex pathobiology. The presence of amyloid-beta (Aβ) depositions and the accumulation of hyperphosphorylated tau protein remain the characteristic hallmarks of AD.
Externí odkaz:
https://doaj.org/article/0e3da743e25b4c0b9eb4e16b0eca6d5d
Autor:
Mai M. Anwar
Publikováno v:
Current Research in Physiology, Vol 4, Iss , Pp 216-222 (2021)
Early diagnosis of neurodegenerative diseases, especially Alzheimer's disease (AD), is essential for implementing the appropriate treatment protocols and controlling disease progression. Early AD diagnosis helps patients achieve the best therapeutic
Externí odkaz:
https://doaj.org/article/88674c7200094834a35dc3384fa3719a
Publikováno v:
eNeurologicalSci, Vol 21, Iss , Pp 100290- (2020)
Serious of unpredictable drawbacks of Coronavirus 2019 (COVID-19) infectious disease caused by SARS-COV-2 on the nervous system, have been widely noticed among the huge number of infected people. It was found that this type of newly revolving pandemi
Externí odkaz:
https://doaj.org/article/4377ddbcca8543b695aff362fc92f15e
Autor:
Mai M. Anwar, Mohamed H. Fathi
Publikováno v:
Neurodegenerative Disease Management. 13:85-99
Aim: To investigate whether the estimation of cerebrospinal fluid (CSF) and brain YKL-40 levels may be used as an efficient biomarker for Parkinson's disease (PD). Methods: Lipopolysaccharides (LPS) was injected into the right substantia nigra pars c
Autor:
Mai M. Anwar, Abeer A. Mabrouk
Publikováno v:
Inflammopharmacology.
Neuroinflammation is a devastating predisposing factor for Alzheimer’s disease (AD). A number of clinical findings have reported peripheral disorders among AD patients. Amyloid beta (Aβ) is a toxic physiological aggregate that serves as a triggeri
Autor:
Mai M. Anwar
Publikováno v:
Cell Biochemistry and Function. 40:17-27
Neurologists have highly observed a frequent increasing number of elderly patients with Alzheimer's disease (AD) without any relevant evidence of any genetic or known AD-linked predisposing factors in the past few years. Those patients are characteri